FDA requests Phase III trial, uniQure (QURE.US) Huntington's disease gene therapy faces listing obstacles, stock price plunges about 33%
Show original
FDA clearly informed this biopharmaceutical company that a randomized, double-blind, sham surgery-controlled Phase III clinical trial must be conducted.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
US regulators downplay concerns over Paramount-Warner Bros. merger
格隆汇•2026/03/03 05:09
NEAR token rises 17% as "Confidential Intents" feature goes live
AIcoin•2026/03/03 05:02
Matrixport-linked whale opens a new 20x leveraged long position with 400 BTC
PANews•2026/03/03 03:42
Matrixport's affiliated address is 20x long 400 BTC, while also holding a long position of 120,000 ETH.
BlockBeats•2026/03/03 03:40
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$68,096.55
+1.76%
Ethereum
ETH
$2,000.03
+1.09%
Tether USDt
USDT
$0.9998
-0.03%
BNB
BNB
$631.56
+1.11%
XRP
XRP
$1.37
+0.07%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$85.97
+1.72%
TRON
TRX
$0.2825
+0.46%
Dogecoin
DOGE
$0.09168
-1.78%
Cardano
ADA
$0.2713
-1.70%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now